Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-01-03 @ 7:57 AM
Study NCT ID:
NCT00003568
Status:
COMPLETED
Last Update Posted:
2013-06-26
First Post:
1999-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
Sponsor:
University of Illinois at Chicago
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CWG-UIC-T98-0027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |